GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Balance Sheet Cash And Cash Equivalents

Chromocell Therapeutics (Chromocell Therapeutics) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.